AMIT RAKHIT, MD
Chief Medical and Portfolio Management Officer, Ovid Therapeutics
Ovid Therapeutics is a publicly traded biotechnology company focused on developing medicines for people living with rare neurologic conditions. Dr. Rakhit oversees the drug development and commercialization path for investigational compounds in the Ovid portfolio. He is a senior healthcare executive with more than 20 years’ experience including both clinical practice and pharmaceutical/biotechnology industry experience. Rakhit earned his Bachelor of Arts in molecular biology from the University of California, Berkeley, his MD from Tufts University School of Medicine, his Master of Science from Vanderbilt University School of Medicine, and dual MBAs from the London Business School and Columbia University. He completed his fellowship in pediatric cardiology and was subsequently on staff at The Children’s Hospital, Boston affiliated with Harvard University.
Prior to Ovid, Rakhit was SVP and Head of Worldwide Medical at Biogen, where he led the medical function for marketed and pipeline compounds in disease areas such as multiple sclerosis, neurodegenerative diseases, hemophilia, spinal muscular atrophy, and amyotrophic lateral sclerosis. Prior to Biogen, Rakhit led an international region at Bristol-Myers Squibb with a cross-therapeutic area portfolio including cardiovascular, metabolics, oncology, HIV, virology, immunology, and neuroscience products.
Rakhit is an advisory member of the Healthcare Board of the Partnership Fund for New York City. He worked with Mother Teresa at the Missionaries of Charity (Kolkata). Rakhit also supports the Human Rights Campaign, and is a co-founder of KoMocean swimwear. He lives with his partner in NYC.